Navigation Links
Guardant Health Named a 2015 Technology Pioneer by World Economic Forum
Date:8/26/2014

REDWOOD CITY, Calif., Aug. 26, 2014 /PRNewswire/ -- Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, has been recognized today by the World Economic Forum as a 2015 Technology Pioneer. As an innovator in non-invasive, tumor profiling, Guardant Health is one of 24 companies across a wide variety of industries and regions to receive this prestigious accolade.

Guardant360®, Guardant Health's first commercially available product, is a first-in-kind blood test that comprehensively sequences a patient's cancer in real-time to aid oncologists in making more informed, personalized treatment decisions without the cost, time, and risk of a traditional tissue biopsy. Guardant360 is built on Digital SequencingTM technology, a proprietary method of capturing and genomically profiling trace fragments of tumor DNA that are shed into the blood stream ("cell-free DNA"), while also providing sequencing information at the single-molecule level. A patient's cancer genomics continues to evolve and change over time due to treatment pressure, which can cause therapy failure.  For the first time, oncologists now have a way to easily track tumor changes with a simple blood test.

In just two years, Guardant Health has taken a promising idea through clinical validation and to commercial launch. Since launch, Guardant360 has demonstrated strong clinical utility as 75% of the genomic alterations identified in the patient specimens are actionable.

"We are honored to be recognized by the World Economic Forum and humbled to be among the esteemed past and present award winners," said Helmy Eltoukhy, Ph.D., Co-founder and Chief Executive Officer of Guardant Health.  "Our mission remains the same: to turn cancer into a manageable disease. We stay committed to ensuring positive impact for patients and helping to reduce both the financial and physical burden of cancer."

About World Economic Forum
The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders of society to shape global, regional and industry agendas.

Incorporated as a not-for-profit foundation in 1971 and headquartered in Geneva, Switzerland, the Forum is tied to no political, partisan or national interests (www.weforum.org).

About Guardant Health

Guardant Health is focused on developing breakthrough diagnostic technologies that possess the ability to transform cancer from a terminal illness to a manageable disease.  Guardant was founded in 2012 by a team of entrepreneurs with high-ranking expertise in next-generation sequencing, single-cell genomics and cancer diagnostics.  Guardant Health is committed to contributing a positive significant impact on patient health through cutting-edge technology that addresses long-standing unmet needs in oncology.    (www.guardanthealth.com)

Logo - http://photos.prnewswire.com/prnh/20140212/SF64352LOGO


'/>"/>
SOURCE Guardant Health
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. AMRI CEO to Present at the Morgan Stanley Global Healthcare Conference
2. 5 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams
3. Telomere Biosciences Announces: TELO-20 for Dogs, the Worlds First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity
4. PAREXEL International To Present At Baird Healthcare Conference
5. Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research
6. Hospira to Present at the Morgan Stanley Global Healthcare Conference
7. Geneva Healthcare Raises $1.8 Million to Expand Data Management for Cardiac Devices to Hospital Systems Nationwide
8. BioHealth Innovation, Inc. Bolsters Board of Directors
9. Increasing Per Capita Spends on Pet Healthcare Drives the Global Animal Medication Market, According to New Report by Global Industry Analysts, Inc.
10. Plant Disease Experts from 45 Countries to Make “Plant Health Connections” in Minneapolis for the APS-CPS Joint Meeting
11. HRTTreatments / Natural Health Research Announces New Intuitive Online Hormone Test, Allowing Clients to Evaluate Possible Hormone Imbalances Easily Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):